These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 7499114)

  • 21. Reporting results of cancer treatment.
    Miller AB; Hoogstraten B; Staquet M; Winkler A
    Cancer; 1981 Jan; 47(1):207-14. PubMed ID: 7459811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation.
    Showalter HD; Johnson JL; Werbel LM; Leopold WR; Jackson RC; Elslager EF
    J Med Chem; 1984 Mar; 27(3):253-5. PubMed ID: 6699870
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma.
    Arseneau JC; Schoenfeld DA; Borden EC
    Invest New Drugs; 1986; 4(1):53-6. PubMed ID: 3700041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.
    Amato DA; Bruckner H; Guerry D; Ash A; Falkson G; Borden EC; Creech RH; Savlov ED; Cunningham TJ
    Invest New Drugs; 1987; 5(3):293-7. PubMed ID: 3667165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current therapy for malignant melanoma.
    Legha SS
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic chemotherapy for metastatic melanoma.
    Mc Clay EF; Mastrangelo MJ
    Semin Oncol; 1988 Dec; 15(6):569-77. PubMed ID: 2462747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).
    Fry DW; Boritzki TJ; Besserer JA; Jackson RC
    Biochem Pharmacol; 1985 Oct; 34(19):3499-508. PubMed ID: 2413861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.
    Hantel A; Donehower RC; Rowinsky EK; Vance E; Clarke BV; McGuire WP; Ettinger DS; Noe DA; Grochow LB
    Cancer Res; 1990 Jun; 50(11):3284-8. PubMed ID: 2334921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole).
    Ames MM; Loprinzi CL; Collins JM; van Haelst-Pisani C; Richardson RL; Rubin J; Moertel CG
    Cancer Res; 1990 Jul; 50(13):3905-9. PubMed ID: 2191768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.
    Falkson CI; Falkson G; Falkson HC
    J Clin Oncol; 1991 Aug; 9(8):1403-8. PubMed ID: 2072144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential chemoimmunotherapy in the treatment of metastatic melanoma.
    Richards JM; Mehta N; Ramming K; Skosey P
    J Clin Oncol; 1992 Aug; 10(8):1338-43. PubMed ID: 1634924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group study.
    Sosman JA; Flaherty LE; Liu PY; Fletcher W; Thompson JA; Hantel A; Sondak V
    Invest New Drugs; 1995; 13(1):83-7. PubMed ID: 7499114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drugs. The anthrapyrazoles.
    Gogas H; Mansi JL
    Cancer Treat Rev; 1996 Nov; 21(6):541-52. PubMed ID: 8599804
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.